A Comparison of the TIMI, GRACE, HEART and HEARTSIL Scores
Comparison of Prognostic Performance of TIMI, GRACE, HEART and HEARTSIL SCORES in Patients Admitted to the Emergency Department With Chest Pain
1 other identifier
observational
600
1 country
1
Brief Summary
Chest pain is one of the most common reasons for emergency admission. Chest pain can be caused by many cardiac and noncardiac causes. Acute Coronary Syndrome (ACS) is one of the most im-portant of these etiologies. ACS has a high mortality rate, but with early diagnosis and related inter-ventions, a high rate of prognosis can be improved. Therefore, early recognition of AKS is impor-tant. However, the challenge in emergency services is not only to identify patients with high risk for ACS. Early detection of low-risk patients is also important for emergency room management. These patients should be discharged quickly with minimal examination and treatment. The follow-up of these patients with the acceptance of ACS brings along unnecessary examinations and treatments. This leads to an increase in healthcare costs and an increase in crowd in emergency services and hospitals. Evaluation of chest pain in the emergency room and early detection of life-threatening conditions such as ACS present many difficulties for clinicians. For this reason, clinicians use some scoring systems that determine the risk stratification of patients and the probability of having acute coronary syndrome. Heart score is one of the scores developed for this purpose. However vital signs are not included in calculating the heart score. Therefore, the investigators considered to include the shock index calcula-ted by systolic blood pressure and pulse in this scoring system. In addition, the investigators have included a very valuable biochemical parameter such as lactate that predicts mortality in many diseases in this scoring system. The investigators named this scoring system HEARTSIL. The investigators aim to compare the diagnostic performance of this score with the diagnostic performance of other scoring systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2020
CompletedFirst Posted
Study publicly available on registry
December 10, 2020
CompletedStudy Start
First participant enrolled
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2021
CompletedApril 26, 2021
December 1, 2020
4 months
December 3, 2020
April 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Major Adverse Cardiac Events (MACE) at 30 days
The primary outcome is MACE at 30 days. MACE is a composite outcome of cardiac death, acute myocardial infarction, and coronary revascularization.
30 days after presentation.
Secondary Outcomes (1)
Major Adverse Cardiac Events (MACE) at 3 days
3 days after presentation.
Interventions
No intervention
Eligibility Criteria
Patients with chest pain.
You may qualify if:
- Patient presenting to the emergency department with chest pain
You may not qualify if:
- ST elevation myocardial infarction,
- Pneumonia, pneumothorax, pulmonary embolism and esophageal rupture
- Patients under 18 years of age
- Pregnant patients
- Patients who do not want to be included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya City Hospital
Konya, 42020, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nazire B Akilli, Assoc Prof
Konya City Hospital
- STUDY CHAIR
Pervin Sagdıc, MD
Konya City Hospital
- STUDY CHAIR
Turgut Uygun, MD
Konya City Hospital
- STUDY CHAIR
Ramazan Koylu, Assoc Prof
Konya City Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
December 3, 2020
First Posted
December 10, 2020
Study Start
February 5, 2021
Primary Completion
June 14, 2021
Study Completion
July 14, 2021
Last Updated
April 26, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share